NMRA FY 2023 Earnings — Neumora Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

NMRANeumora Therapeutics, Inc. Common Stock

$586M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$668,000

Operating Income

-$188M

Net Income

-$236M

EPS (Diluted)

$-1.49

Cash Flow

Operating Cash Flow

-$163M

Free Cash Flow

-$163M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$496M

Total Liabilities

$27M

Stockholders' Equity

$469M

Cash & Equivalents

$374M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$668,000	$0	—
Operating Income	-$188M	-$136M	-38.5%
Net Income	-$236M	-$131M	-80.2%